Income Statement (PACIFIC/BIOSCIENCES)

Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NASDAQ:PACB) deliv… [+1627 chars]...

In This Article:Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NA… [+146 chars]...

Sumitomo Mitsui Trust Group Inc. trimmed its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.0% in the 1st quarter, according to the company in its most… [+5311 chars]...

The Telomere-to-Telomere Consortium recently finished the first truly complete sequence of a human genome. To resolve the most complex repeats, this project relied on the semimanual combination of … [+1422 chars]...

Accurate genome assemblies are essential for biological research, but even the highest-quality assemblies retain errors caused by the technologies used to construct them. Base-level errors are typi… [+1497 chars]...

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Hold” from the nine analysts that are covering the stock, Marketbeat reports. Five ana… [+4748 chars]...